A Contribution of Novel Cnvs to Schizophrenia from a Genome-Wide Study of 41,321 Subjects
bioRxiv preprint doi: https://doi.org/10.1101/040493; this version posted February 23, 2016. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. A contribution of novel CNVs to schizophrenia from a genome-wide study of 41,321 subjects CNV Analysis Group and the Schizophrenia Working Group of the Psychiatric Genomics Consortium Christian R. Marshall1*, Daniel P. Howrigan2,3*, Daniele Merico1*, Bhooma Thiruvahindrapuram1, Wenting Wu4,5, Douglas S. Greer4,5, Danny Antaki4,5, Aniket Shetty4,5, Peter A. Holmans6,7, Dalila Pinto8,9, Madhusudan Gujral4,5, William M. Brandler4,5, Dheeraj Malhotra4,5,10, Zhouzhi Wang1, Karin V. Fuentes Fajarado4,5, Stephan Ripke2,3, Ingrid Agartz11,12,13, Esben Agerbo14,15,16, Margot Albus17, Madeline AleXander18, Farooq Amin19,20, Joshua Atkins21,22, Silviu A. Bacanu23 ,Richard A. Belliveau Jr3, Sarah E. Bergen3,24, Marcelo Bertalan16,25, Elizabeth Bevilacqua3, Tim B. Bigdeli23, Donald W. Black26, Richard Bruggeman27, Nancy G. Buccola28, Randy L. Buckner29,30,31, Brendan Bulik-Sullivan2,3, William Byerley32, Wiepke Cahn33, Guiqing Cai8,34, Murray J. Cairns21,35,36, Dominique Campion37, Rita M. Cantor38, Vaughan J. Carr35,39, Noa Carrera6, Stanley V. Catts35,40, Kimberley D. Chambert3, Wei Cheng41, C. Robert Cloninger42, David Cohen43, Paul Cormican44, Nick Craddock6,7, Benedicto Crespo-Facorro45,46, James J. Crowley47, David Curtis48,49, Michael Davidson50, Kenneth L, Davis8, Franziska Degenhardt51,52, Jurgen Del Favero53, Lynn E. DeLisi54,55, Ditte Demontis16,56,57, Dimitris Dikeos58, Timothy Dinan59, Srdjan Djurovic11,60, Gary Donohoe44,61, Elodie Drapeau8, Jubao Duan62,63, Frank Dudbridge64, Peter Eichhammer65, Johan Eriksson66,67,68, Valentina Escott-Price6, Laurent Essioux69, Ayman H.
[Show full text]